Temple Health physicians and scientists are finding innovative solutions to treat complex conditions, create better options and develop next-generation treatments. Find out how Temple Health is helping more patients live better lives.
Leading the region with state-of-the-art approaches to robotic spine surgery, Temple physicians are performing more minimally invasive and precise surgeries, helping patients achieve their best outcomes sooner.
Continuing a lifelong dedication to improving women’s health outcomes from Philadelphia to South America, Dr. Jack Ludmir is bringing his visionary leadership to the highly anticipated Temple Women & Families Hospital, planned to open in 2024.
Seeing an opportunity to make lung cancer screenings go further, the Temple Healthy Chest Initiative employs dedicated nurse navigators who go the extra mile to support patients through any results their scans may reveal, and help ensure they get the resources needed.
Knowing that stable housing is one of the most impactful social determinants of health, Steven Carson, MHA, BSN, RN, began an initiative to address homelessness within the Temple community—and the impact is astounding.
After promising findings of potential synergistic effects of combining immunotherapy with an existing cancer drug, Fox Chase Cancer Center research has inspired a new clinical trial for patients with melanoma.
Dissatisfied with current treatments for DVT and PE, Dr. Riyaz Bashir designed a new solution that uses a specialized catheter and the body’s own blood to dissolve clots much more quickly and with less medication than current methods.
Over the past 7 years, the Temple Lung Center has performed more lung transplants than any other hospital in the country. We're also one of the first to transplant a patient with post-COVID lung failure.
The Temple MDA/ALS Center of Hope is a national leader in helping people with ALS and other neuromuscular diseases manage their condition, offering specialized care and clinical trials not found at most hospitals.
A recognized leader in the development of new pulmonary therapies, Temple physicians have led the development of a breakthrough treatment option for patients with severe emphysema.
While managing some of the highest COVID-19 volumes in Philadelphia, Temple’s medical team has simultaneously achieved survival rates far better than the national and regional averages.
Attracting patients from across the country, Temple is delivering the cure for a rare form of pulmonary hypertension called CTEPH.
Through extensive collaboration with research colleagues throughout the country, Temple is a national leader in helping patients with lung disease live their healthiest lives.
Temple robotic surgeons are making it possible for more patients to receive livesaving therapies after being told they were out of options.
Adult patients who are suffering from tracheobronchomalacia (TBM) — a collapse of the windpipe and bronchial tubes — can find expertise at Temple, a destination center for this rare condition.
Temple researchers are leveraging CRISPR technology that may be an effective pathway to ridding people infected with HIV of the virus without harming them.
Over 200 hospitals throughout the region depend on Temple to care for their most critically injured and sick patients.
For over 20 years, Temple has been the regional leader in providing burn care for the most serious burns.